103 related articles for article (PubMed ID: 22945782)
21. Chronic Kidney Disease and Lipid Disorders.
Zubovic SV; Kristic S; Prevljak S; Pasic IS
Med Arch; 2016 Jun; 70(3):191-2. PubMed ID: 27594744
[TBL] [Abstract][Full Text] [Related]
22. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Charytan DM; Lewis EF; Desai AS; Weinrauch LA; Ivanovich P; Toto RD; Claggett B; Liu J; Hartley LH; Finn P; Singh AK; Levey AS; Pfeffer MA; McMurray JJ; Solomon SD
Am J Kidney Dis; 2015 Sep; 66(3):429-40. PubMed ID: 25935581
[TBL] [Abstract][Full Text] [Related]
23. Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
Nanayakkara PW; Kiefte-de Jong JC; ter Wee PM; Stehouwer CD; van Ittersum FJ; Olthof MR; Teerlink T; Twisk JW; van Guldener C; Smulders YM
Am J Kidney Dis; 2009 Jan; 53(1):41-50. PubMed ID: 18786751
[TBL] [Abstract][Full Text] [Related]
24. Clinical study of total glucosides of paeony for the treatment of diabetic kidney disease in patients with diabetes mellitus.
Zhu Q; Qi X; Wu Y; Wang K
Int Urol Nephrol; 2016 Nov; 48(11):1873-1880. PubMed ID: 27342654
[TBL] [Abstract][Full Text] [Related]
25. Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus.
Ashraf R; Aamir K; Shaikh AR; Ahmed T
J Ayub Med Coll Abbottabad; 2005; 17(3):60-4. PubMed ID: 16320801
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Serum Glucose and Kidney Disease Progression Among Patients With Diabetes.
Jung HH
JAMA Netw Open; 2021 Sep; 4(9):e2127387. PubMed ID: 34586368
[TBL] [Abstract][Full Text] [Related]
27. Serum homocysteine levels in renal transplant recipients with and without hypercholesterolemia.
Piovesan F; Veronese FJ; Santos AF; Pozza R; Sarturi PS; Tognon A; Garcia VD; Keitel E; Saitovitch D
Arq Bras Cardiol; 2007 Sep; 89(3):154-9, 170-5. PubMed ID: 17906816
[TBL] [Abstract][Full Text] [Related]
28. Effect of prickly pear (Opuntia robusta) on glucose- and lipid-metabolism in non-diabetics with hyperlipidemia--a pilot study.
Wolfram RM; Kritz H; Efthimiou Y; Stomatopoulos J; Sinzinger H
Wien Klin Wochenschr; 2002 Oct; 114(19-20):840-6. PubMed ID: 12503475
[TBL] [Abstract][Full Text] [Related]
29. Renoprotective effects of (+)-catechin in streptozotocin-induced diabetic rat model.
Chennasamudram SP; Kudugunti S; Boreddy PR; Moridani MY; Vasylyeva TL
Nutr Res; 2012 May; 32(5):347-56. PubMed ID: 22652374
[TBL] [Abstract][Full Text] [Related]
30. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
Shehata M; Hamza M
Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency.
Li Vecchi M; Fuiano G; Francesco M; Mancuso D; Faga T; Sponton A; Provenzano R; Andreucci M; Tozzo C
Nephron Clin Pract; 2007; 105(2):c62-7. PubMed ID: 17135770
[TBL] [Abstract][Full Text] [Related]
32. [Relationship between nonalcoholic fatty liver disease markers and renal function in patients with type 1 diabetes].
Bulum T; Duvnjak L
Acta Med Croatica; 2011 Oct; 65 Suppl 3():6-10. PubMed ID: 23120807
[TBL] [Abstract][Full Text] [Related]
33. Lipids in the progression of chronic renal failure.
Cappelli P; Evangelista M; Bonomini M; Palmieri PF; Albertazzi A
Nephron; 1992; 62(1):31-5. PubMed ID: 1436288
[TBL] [Abstract][Full Text] [Related]
34. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.
Lewis EJ; Hunsicker LG; Bain RP; Rohde RD
N Engl J Med; 1993 Nov; 329(20):1456-62. PubMed ID: 8413456
[TBL] [Abstract][Full Text] [Related]
35. Comparative evaluation of fosinopril and herbal drug Dioscorea bulbifera in patients of diabetic nephropathy.
Singh RG; Rajak M; Ghosh B; ; Agrawal A; Dubey GP
Saudi J Kidney Dis Transpl; 2013 Jul; 24(4):737-42. PubMed ID: 23816723
[TBL] [Abstract][Full Text] [Related]
36. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
Smulders YM; Rakic M; Slaats EH; Treskes M; Sijbrands EJ; Odekerken DA; Stehouwer CD; Silberbusch J
Diabetes Care; 1999 Jan; 22(1):125-32. PubMed ID: 10333913
[TBL] [Abstract][Full Text] [Related]
37. Salacia reticulata improves serum lipid profiles and glycemic control in patients with prediabetes and mild to moderate hyperlipidemia: a double-blind, placebo-controlled, randomized trial.
Shivaprasad HN; Bhanumathy M; Sushma G; Midhun T; Raveendra KR; Sushma KR; Venkateshwarlu K
J Med Food; 2013 Jun; 16(6):564-8. PubMed ID: 23767865
[TBL] [Abstract][Full Text] [Related]
38. Chronic kidney disease and underdiagnosis of renal insufficiency among diabetic patients attending a hospital in Southern Ethiopia.
Fiseha T; Kassim M; Yemane T
BMC Nephrol; 2014 Dec; 15():198. PubMed ID: 25511372
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria.
Fruehwald-Schultes B; Kern W; Beyer J; Forst T; Pfützner A; Peters A
Metabolism; 1999 Oct; 48(10):1290-3. PubMed ID: 10535393
[TBL] [Abstract][Full Text] [Related]
40. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
